Floatz logo

Pregabalin

Radiculopathy

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Small moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Radiculopathy cohort.

Asset / SponsorPhaseRating
Triamcinalone
University of Miami
Phase 4BBB
LIDOCAINE
Sheba Medical Center
Phase 4BBB
sp-102
Semnur Pharmaceuticals, Inc.
Phase 3BB
DEXAMETHASONE
Semnur Pharmaceuticals, Inc.
Phase 4BB
Celestone
Sheba Medical Center
Phase 4BB

View all 35 →

Same molecule, other indications

Pregabalin is also rated in:

focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →
peripheral neuropathyDormant
A
Indicative ·
82 / 100
View asset →
Depressive Disorder, MajorDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →